Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures

Abstract

Andexanet alfa may be used for urgent or emergent reversal of apixaban and rivaroxaban peri-procedurally with promising hemostatic outcomes. Further prospective, comparative clinical research is warranted.